PDB37 Injection of Long-Acting Somatostatin Analogs: A Cost Consequence Analysis for Three European Countries
نویسندگان
چکیده
منابع مشابه
Long-acting risperidone injection: efficacy, safety, and cost-effectiveness of the first long-acting atypical antipsychotic
OBJECTIVE To review the pharmacokinetics, efficacy, safety, and cost-effectiveness of long-acting risperidone. METHODS Studies published between January 2000 and October 2006 evaluating the pharmacokinetics, efficacy, safety, and cost-effectiveness of long-acting risperidone were reviewed, as identified from literature searches using Medline and EMBASE. Abstracts and posters on long-acting ri...
متن کاملLong-Acting Human Insulin Analogs
Endogenous insulin is a hormone secreted by the beta cells of the pancreatic islets of Langerhans. Insulin acts via specific membrane-bound receptors on target tissues to regulate metabolism of carbohydrates, proteins and fats. Exogenous insulin, manufactured for pharmacologic use through recombinant DNA technology using either E. coli or Saccharomyces cerevisiae is used as replacement therapy ...
متن کاملEvaluation of long-acting somatostatin analog injection devices by nurses: a quantitative study
The somatostatin analogs (SSAs) lanreotide Autogel/Depot and octreotide long-acting release are used to treat acromegaly and neuroendocrine tumors. The present study evaluated opinions on SSA injection devices, including a recently approved lanreotide new device (lanreotide-ND), among nurses in Europe and the USA. Nurses injecting SSAs for at least three patients per year (n = 77) were intervie...
متن کاملPrescription patterns of long-acting somatostatin analogues
BACKGROUND Acromegaly and endocrine tumors are uncommon morbidities that are currently treated with different drugs. OBJECTIVE To determine the prescription patterns of somatostatin analogues in patients affiliated with the Health System of Colombia. METHODS Retrospective cohort study of patients of any age and sex treated with octreotide or lanreotide between January 2011 and August 2015. ...
متن کاملGastric endocrine tumors type I: treatment with long-acting somatostatin analogs.
Gastric endocrine tumors associated with autoimmune chronic atrophic gastritis (gastric carcinoid type I) are almost exclusively benign lesions with little risk of deep invasion of the gastric parietal wall. For this reason, the role of octreotide in the treatment of these neoplastic lesions is controversial. Nine patients with more than five type I gastric endocrine tumors each <1 cm in size, ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Value in Health
سال: 2011
ISSN: 1098-3015
DOI: 10.1016/j.jval.2011.08.1340